Evidence map›Paper›PMID 42138329›Full record

ReviewMedicinal research reviews2026

Quantification of

Christoph Selg, Wolfgang A G Sauerwein, Evamarie Hey-Hawkins

Abstract readReview
In one paragraph

Review in Medicinal research reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Christoph SelgCentre for Biotechnology and Biomedicine (BBZ), Institute of Bioanalytical Chemistry, Faculty of Chemistry, Leipzig University, Leipzig, Germany.
Wolfgang A G SauerweinDepartment for Radiation Oncology, Deutsche Gesellschaft für Bor-Neutroneneinfangtherapie e. V. (DGBNCT), University Hospital Essen, Essen, Germany.
Evamarie Hey-HawkinsCentre for Biotechnology and Biomedicine (BBZ), Institute of Bioanalytical Chemistry, Faculty of Chemistry, Leipzig University, Leipzig, Germany.

Funding

Deutsche Forschungsgemeinschaft HE 1376/61-1European Union-NextGenerationEU 760240/28.12.2023Romanian Ministry of Research, Innovation and Digitalization
6 · The paper itself

Abstract

Boron neutron capture therapy (BNCT) is a targeted radiotherapy that exploits the selective accumulation of the

Indexed as

BoronBoron Neutron Capture TherapyTranslational Research, BiomedicalAnimalsHumansIsotopesNeoplasmsBoronBoron-10Isotopesaccelerator‐based neutron sourcesboron isotope analysisclinical dosimetrymass spectrometry imagingmultimodal molecular imagingneutron capture spectroscopytheranostics

Identifiers

PMID42138329
PMCPMC13441364

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.